你即將離開本站

並前往https://www.mirati.com/science/programs/kras-inhibitors/kras-g12d-inhibitor/

KRAS G12D Inhibitor - Mirati Therapeutics, Inc.

Mechanism of Action. Mirati is developing investigational drug candidate, MRTX1133, which is optimized to inhibit KRASG12D and has the potential to be a ...

確定！ 回上一頁

查詢 「KRAS G12D」的人也找了：

  1. KRAS G12D inhibitor
    2.
  2. kras基因
    3.
  3. Sotorasib
    4.
  4. kras是什麼
    5.
  5. KRAS G12C
    6.
  6. KRAS mutation
    7.
  7. KRAS G12D lung cancer
    8.
  8. kras突變
    9.